Prevention and treatment of mucositis and dermatitis caused by radiotherapy, chemotherapy and combined treatments
Supportive
Care
IN COMBINATION
Association with existing therapies possible
UNIQUE FORMULA
Hyaluronic acid(HA) and a patented cluster of amino acids(AA) that help
promote regeneration of tissue and relief pain by forming a protective barrier
EVIDENCE BASED
Clinically proven efficacy in improving prevention and treatment of oral mucositis / actinic proctitis / actinic vaginitis in various cancers during radio and chemotherapy
IMPROVED PATIENT COMPLIANCE
Water-based formulation (ethanol free) Cost-effective with a broad range of functions
NO SAFETY CONCERN
HA and AA being biomaterials, no treatment-related adverse events and can be used for a long period without concern
Mucosamin®
Mouthwash
Adjuvant in the regenerative process of the oral mucosa and prevention of oral mucositis caused by radio or chemotherapy
Mucosamin®
Spray
Adjuvant in the regeneration process of oral mucosa in mucositis caused by radio and chemotherapy with rapid pain relief
Mucosamin®
Rectal Gel
Treatment of actinic proctitis induced by radiotherapy on the pelvic district and proctitis during chemotherapy or radio-chemotherapy
Mucosamin®
Vaginal Cream
Treatment of actinic vulvovaginitis induced by radiotherapy on the pelvic district and in vulvovaginitis during chemotherapy or combined radiotherapic treatment
Medical Device
class IIa
Medical Device
class IIa
Medical Device
class IIb
Medical Device
class IIb
Mucosamin®
Mouthwash
Adjuvant in the regenerative process of the oral mucosa and prevention of oral mucositis caused by radio or chemotherapy
Medical Device
class IIa
Mucosamin®
Spray
Adjuvant in the regeneration process of oral mucosa in mucositis caused by radio and chemotherapy with rapid pain relief
Medical Device
class IIa
Mucosamin®
Rectal Gel
Treatment of actinic proctitis induced by radiotherapy on the pelvic district and proctitis during chemotherapy or radio-chemotherapy
Medical Device
class IIb
Mucosamin®
Vaginal Cream
Treatment of actinic vulvovaginitis induced by radiotherapy on the pelvic district and in vulvovaginitis during chemotherapy or combined radiotherapic treatment
Medical Device
class IIb
PRESERVE SKIN BARRIER
To preserve the functions of the skin barrier To delay exfoliation of the skin
SLOW LESION
To slow lesion evolution (exudation, scabs, necrosis)
Radioderm®
Spray
Prevention and treatment of radiodermatitis.
Medical Device
class IIa